Clearside Biomedical's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Clearside Biomedical (NASDAQ:CLSD) is scheduled to release its quarterly earnings report on Monday, 2023-11-13, with analysts expecting an EPS of $-0.15. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, CLSD missed EPS estimates by $0.01, resulting in a 6.6% share price drop the following day. Over the past year, CLSD shares have declined by 33.8%.
November 10, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Clearside Biomedical is expected to report an EPS of $-0.15 for the latest quarter. Historical data shows that earnings misses have negatively impacted the stock price, with a 6.6% drop after last quarter's miss. Shares have decreased by 33.8% over the last 52 weeks.
Given the historical sensitivity of CLSD's stock price to earnings performance and the overall negative trend over the past year, there is a likelihood of a negative short-term impact if the company fails to meet or exceed the EPS estimate or provides weak guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100